August 2023 – Vocxi Health and S3 Connected Health Partner to Transform Lung Cancer Screening and Monitoring

August 2023 – Vocxi Health and S3 Connected Health Partner to Transform Lung Cancer Screening and Monitoring

Congratulations to Avalon Securities client Vocxi Health, a breath diagnostics company, for partnering with S3 Connected Health to bring game-changing technology to market for transforming lung cancer detection and monitoring. Vocxi Health has patented technology to deliver a smart device, the BreathEZ, designed to detect lung cancer from volatile organic compounds with just one minute of breathing. This breakthrough technology aims to make late stage diagnoses a thing of the past, promising earlier detection and improved outcomes for patients. Lung cancer is responsible for over 1.8 mm deaths globally every year, but early detection leads to a 10X improvement in survival rates. Vocxi Health has partnered with S3 Connected Health for full end-to-end delivery of their digital health solution, and S3 Connected Health’s digital health platform Affinial, the most comprehensive platform for life science companies to create regulated digital health solutions, will be used as the basis upon which the custom mobile app and cloud-based solution will be built. Vocxi Health also plans to leverage Affinial’s efficiencies in scaling solutions to facilitate their future plans for the BreathEZ, including potential expansion into other disease areas.

For the full article, follow this (LINK).